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Abstract  
BACKGROUND: Directly observed therapy (DOT) is a specific strategy endorsed by the World Health 
Organization in 1994 to improve adherence by requiring health workers, community volunteers or family members 
to observe and record tuberculosis (TB) patients for taking each dose. The implementation of DOT strategy in the 
National Tuberculosis Programme (NTP) in Macedonia was introduced in 2006 and was realised by 6 nurses 
engaged through the Project of Global Fund against HIV/AID and TB. 
AIM: This study aimed to evaluate how these visits conducted by the DOT nurses engaged through the GF were 
accepted by TB patients and to evaluate the impact on the treatment outcomes. 
PATIENTS AND METHODS: In this prospective study 105 TB patients who started treatment in 2016 and who 
were supposed to be visited by DOT nurses at their homes were included. All of these patients filled out a 
questionnaire compiled of 6 questions related to their opinion about the efficacy and usefulness of the visits 
managed by the nurses when they would come for check-ups at the Institute for Lung Diseases and Tuberculosis. 
The assessment of the efficacy of the work of DOT nurses was performed by analysis of the answers received by 
TB patients. The data were analysed with the method of description and was statistically prepared in the program 
SPSS for Windows, 17.0. 
RESULTS: The results from the analyses showed that the number of visited patients were not satisfied, because 
29.52%% were never visited by a DOT nurse at their homes. A lot of patients (61.91%) were not willing to take 
medicines under the observed control by nurses. Those TB patients who were visited by DOT nurses thought that 
this type of visit is useful for them: they were satisfied by the attitude of the nurses during the visits, and they 
received enough explanations regarding TB. 
CONCLUSION: We can conclude that the DOT visits to TB patients are useful, contribute patients to complete 
the therapeutic regime without interruption, take care for every individual patient effectively, and protect the rest of 
society by preventing the development and spread of TB, including drug-resistant strains. 
 
 
 
 
 
 
 
 
Introduction 
 
Despite the widespread availability of cheap, effective 
treatment, tuberculosis (TB) remains a major cause of 
severe illness and death, with an estimated nine 
million new cases and two million deaths occurring 
annually [1]. One barrier to global TB control is the 
long duration of TB treatment- a minimum of six 
months- which frequently results in patients taking 
their medications erratically or not at all [2]. 
Interruption of the treatment can lead to relapse and 
even death in individuals, and also has important 
public health consequences, such as increased TB 
transmission and development of drug resistance [3]. 
Directly observing TB patients taking their anti-TB 
therapy, either daily or several times per week, was 
first piloted in the 1950s as a way to ensure 
adherence and treatment completion [2] In 1994, 
based on the reported success of directly observed 
therapy (DOT) in increasing treatment completion 
rates and preventing drug resistance, the World 
Health Organization (WHO) adopted DOT as a 
principal component of its global TB control strategy 
named as DOTS - Directly Observed Treatment 
Short-course strategy [4].  
DOT is a specific strategy endorsed to 
improve adherence by requiring health workers, 
community volunteers or family members to observe 
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and record patients taking each dose. Cure rates in 
DOTS programs have been reported to be as high as 
95%, and the World Bank considers the DOTS 
strategy to be one of today’s most cost-efficient health 
interventions [5]. 
Although WHO and other international 
agencies strongly advocate DOT, controversy remains 
whether its benefits have been proven. Randomized 
controlled trials (RCT) have shown either modest or 
no benefit of DOT in improving TB treatment success 
rates, and a meta-analysis of 10 RCTs concluded that 
the evidence base for WHO's DOT policy is 
insufficient. A recent Cochrane review reports no 
beneﬁt from DOT on adherence and cure rates when 
compared with self-administered treatment (SAT) 
regimens [6]. The effectiveness of DOT, it has been 
argued, should be judged by how well it prevents drug 
resistance, specifically to rifampicin, and not by 
improvements in treatment success rates [7]. 
The implementation of DOT strategy in 
Macedonia started in 2004, but all principles and 
activities in the National Tuberculosis Programme 
(NTP) were introduced in 2006. In the period from 
2006-2016 when the Project of Global Fund against 
HIV/AID and TB (GF) was presented in Macedonia 
with significant financial support to our NTP, DOT 
activities were realised in a big proportion from 6 
nurses engaged through the GF. A small part of DOT 
activities was controlled by the nurses from public 
health institutions. The role of the DOT nurses was to 
visit TB patients at their homes especially during the 
continuous phase of treatment regime few times per 
week with the aim to observe the intake of medicines, 
to educate TB patients about diseases and to provide 
social or some other kind of support where it was 
needed. DOT nurses from the GF covered TB patients 
from the four biggest cities in the country.  
The objective of this study was to evaluate 
how these visits conducted by DOT nurses engaged 
through the GF were accepted by TB patients and to 
evaluate the impact over treatment outcomes. 
 
 
Patients and Methods 
 
In this prospective study, 105 patients were 
included who were considered to be eligible due to 
confirmed TB disease and who started treatment in 
2016. Out of the total number of TB patients who were 
supposed to be visited by DOT nurses at their homes, 
this group of 105 TB patients was randomly selected. 
The general information regarding TB patients was 
provided from the evidence of DOT nurses engaged 
through the GF. The data regarding the disease of the 
patients like treatment outcomes were obtained from 
the electronic base of the Central Register for TB 
patients from the Institute for Lung Diseases and 
Tuberculosis.  
All of these patients received a questionnaire 
comprised of 6 questions prepared by the doctors 
from the Institute for Lung Diseases and Tuberculosis. 
The questions were related to the opinion of TB 
patients for the satisfaction and usefulness of the 
visits managed by the nurses.  
The patients filled out the questionnaires 
when they would come for check-ups at the Institute 
for Lung Diseases and Tuberculosis. This activity was 
conducted and controlled by 3 nurses from the 
Institute, who was not part of the DOT activity 
organised by the GF. So we conducted the 
assessment of the nurses’ engagement in DOT 
through the questionnaire filled out by TB patients.  
 
Statistical analyses 
The data were analysed with the method of 
description and was statistically prepared in the 
program SPSS for Windows, 17.0. 
 
 
Results 
 
In the next text, we present the analyses of 
the patient
, 
s answers to all 6 questions from the 
questionnaire separately: 
 
Question No1. How many times per month 
were you visited by DOT nurses? 
According to the results, one third 31(29.52%) 
was never visited by DOT nurses. 74 patients 
(70.47%) were visited during their TB treatment: 32 
(30.48%) were visited less than 3 times per month, 
the same were visited between 3 and 9 times, and 10 
patients were visited more than 10 times per month 
(9.52%) (Table 1).  
Table 1: Number of DOT visits per month to TB patients 
How many times per month were you visited by DOT 
nurses? 
n (%) 
Never 31 (29.52) 
<3 times 32 (30.48) 
3 – 9 times 32 (30.48) 
 >10 times 10 (9.52) 
Total  105 (100.0) 
 
Question No 2. What was the attitude like 
of the DOT nurses towards you during the 
visits? 
Nearly all TB patients (73-69.52 %) who were 
visited by a DOT nurse answered that the DOT nurse 
had a good positive attitude towards them. Only one 
patient was dissatisfied from the nurse
, 
s attitude 
(Table 2).  
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Table 2: The attitude of DOT nurses towards TB patients during 
the visits 
What was the attitude like of the DOT nurses towards you 
during the visits? 
n (%) 
Not visited 31 (29.52) 
Good 73 (69.52) 
Bad 1 (0.95) 
Total  105 (100.0) 
 
Question No 3. Do you find the DOT 
nurses’ visits useful for you?  
Regarding the usefulness of DOT nurses’ 
visits except for 2 patients, the others thought that that 
kind of visits was very useful for them and their 
disease (Table 3).  
Table 3: Assessment of the usefulness of DOT nurses’ visits 
Do you find the DOT nurses’ visits useful for you? n (%) 
Not visited 31 (29.52) 
Yes 72 (68.57) 
No 2 (1.9) 
Total  105 (100.0) 
 
Question No 4. Were you satisfied with the 
DOT nurses’ answers to your questions 
regarding your disease? 
As for the question about the TB patients’ 
satisfaction and the answers received by DOT nurses, 
73(69.52%) answered positively with “yes (Table 4). 
Only 1 patient was dissatisfied with the answer to the 
questions regarding the disease.  
Table 4: Satisfaction of TB patients to the answers regarding 
their disease received by a DOT nurse 
Were you satisfied with the DOT nurses’ answers to your 
questions regarding your disease? 
n (%) 
Not visited 31 (29.52) 
Yes 73 (69.52) 
No 1 (0.95) 
Total  105 (100.0) 
 
Question No 5: Did you take the medicines 
under the nurses’ control? 
The results showed that most of the visited 
patients (65 - 61.91%) did not take the medicines 
under the nurses’ control. It was odd that only 9 
patients (8.57%) took medicines during the visits of 
DOT nurses (Table 5).  
Table 5: Were the TB patients observed when they took the 
medicines? 
Did you take the medicines under the nurses’ control? n (%) 
Not visited 31 (29.52) 
Yes 9 (8.57) 
No 65 (61.91) 
Total  105 (100.0) 
 
Question 6: Treatment outcomes of TB 
patients 
At the time when we finished this study, all of the TB 
patients who started treatment in 2016 and were 
included in the study, did not finish their therapeutic 
regime. So, the treatment outcomes of these 105 TB 
patients were: 36 or 34.29% still on treatment, 
treatment completed 64 or 60.95% and those who 
died 5 or 4.76% (Table 6). If we exclude those 36 TB 
patients who were still on treatment, the number of 
patients that remained for assessment regarding the 
known treatment outcomes was 69. 
Table 6: Treatment outcomes of TB patients 
Treatment outcomes n (%) 
Treatment completed 64 (60.95) 
Died 5 (4.76) 
Still on treatment 36 (34.29) 
Total  105 (100.0) 
 
We performed statistical analyses by applying 
the Fisher exact test to see if there is a correlation 
between the number of visits to the patient
’
s home by 
the DOT nurses and the treatment outcomes. The 
results showed that there were statistically significant 
differences between the number of visits and 
treatment outcomes (p < 0.008). Most of TB patients 
who completed the treatment (24-37.5%) were visited 
3-9 times per month, followed by the group of 21 
patients (32.81%) that were visited less than 3 times 
per month. We have to note that among patients 
never visited at their homes; there were 12 (18.75%) 
who completed treatment. In regard to the patients 
who have died, we have information from the medical 
documentation that those were older patients with 
comorbidities: these types of patients should be 
visited more times at their homes, not less than 3 
according to the results. 
What is characteristic among the active TB 
patients who are still in treatment, half of them (50%) 
have not been visited by DOT nurses not even once. 
Table 7: Correlation between the number of visits by the DOT 
nurses and treatment outcomes 
The number of visits by the 
DOT  
Treatment outcomes 
Completed Died Still on treatment 
Never 12 (18.75) 1 (20) 18 (50) 
<3 times 21 (32.81) 4 (80) 7 (19.44) 
3 – 9 times 24 (37.5) 0 8 (22.22) 
>10 times 7 (10.94) 0 3 (8.33) 
Fisher exact p < 0.008 
 
 
 
Discussion 
 
TB incidence in the Republic of Macedonia 
has declined during the last ten years and from 
27.8/100 000 inhabitants in 2007, dropped to 12.9/100 
000 inhabitants in 2016 (absolute number of 267 new 
TB cases in 2016). In this period the treatment 
success rate was between 86.3% and 91.3% of all 
registered cases. Regarding multidrug-resistance TB 
(MDR-TB), there are only 2-4 new cases per year (2 
cases in 2016). 
These positive results are due to all activities 
performed through our NTP in which DOT presents an 
important portion (part). DOT is designed to promote 
proper adherence to the full course of drug therapy to 
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improve patient outcomes and prevent the 
development of drug resistance.  
The results from the analyses showed that the 
number of visited patients was not satisfactory, 
because 29.52%% were never visited by a DOT nurse 
at their home at all. The explanation for the reason 
why DOT nurses did not visit these TB patients was 
that some of these patients had support from other 
family member or some patients refused to be visited 
without reason or because of stigma. It is correct that 
DOT nurses should assess that of the patients should 
be visited less than it was recommended, especially in 
the case when the patients are aware and educated 
about their disease well enough. We know that stigma 
in our country is a big problem among TB patients and 
sometimes can be a barrier for diagnosing TB in time, 
starting with treatment and curing the disease.  
But in those TB patients who were visited by 
DOT nurses, nearly all cases thought that this type of 
visit is useful for them: they are satisfied by the 
attitude of the nurses during the visits, and they 
received enough explanations regarding TB. 
 A lot of patients (61.91%) were not willing to 
take medicines under the observed control by nurses. 
Only 8.57% of patients answered that they accepted 
to take medicine when the nurses had visited their 
homes. 
Regarding the treatment outcomes, we found 
statistically significant differences between the 
number of visits and treatment outcomes: nearly half 
of the patients who completed treatment (48.44%) 
were visited more than 3 times per month. TB patients 
who died during the treatment were visited less than 3 
times per month because the time of death had 
happened at the beginning of the treatment regime. 
However, the analyses showed that there was good 
compliance by the patients, good adherence to the 
treatment, good cooperation between patients and 
nurses which led to the completion of the treatment 
and cure without any patients who interrupted the 
treatment. Also, to improve patients’ adherence to the 
treatment, packages with food and hygiene products 
were provided as an incentive by the GF in the RM. In 
this study, we did not conduct the analysis how DOT 
strategy influenced to the country economic burden. 
The rates of success of different DOT 
programs reported in the literature shows great 
variability.  
Six trials from South Africa, Thailand, Taiwan, 
Pakistan and Australia compared DOT with self-
administered therapy for treatment. Trials included 
DOT at home by family members, community health 
workers (who were usually supervised); DOT at home 
by health staff; and DOT at health facilities. TB cure 
was low with self-administration across all studies 
(range 41% to 67%), and direct observation did not 
substantially improve this (RR 1.08, 95% CI 0.91 to 
1.27; five trials, 1645 participants). Treatment 
completion showed a similar pattern, ranging from 
59% to 78% in the self-treatment groups, and direct 
observation did not improve this (RR 1.07, 95% CI 
0.96 to 1.19; six trials, 1839 participants [8]. 
A meta-analysis on the efficacy of DOT, which 
included 32 studies, reported that only 11 of those 
were prospective, and of these only two were 
randomised clinical trials. The majority of the TB 
programs included in that meta-analysis incorporated 
other components besides the ﬁve key elements of 
the WHO-recommended DOTS strategy, with great 
heterogeneity within programs [9]. These other 
components included incentives, facilitators, follow-up 
of defaulters, legal sanctions, and patient centred-care 
and health personnel motivation programs [10]. The 
potential confounding effect of such co-interventions 
was evident. In general, DOT completion rates are 
significantly higher for those receiving DOT plus an 
incentive than for those receiving DOT without 
incentives [11]. To focus exclusively on supervised 
swallowing of the pills must be considered as an 
extremely simplistic approach to a very complex 
problem. Patient adherence is multifaceted and is 
affected by several factors that range from the 
individual’s characteristics to the qualities of the social 
environment [12]. To attain acceptable rates of 
treatment adherence might require additional social 
services and economic incentives [9] [13]. 
The DOTS strategy imposes an additional 
economic burden on the health system of a country, 
and also on the patients treated under this regimen 
due to the need for the system to provide the 
necessary infrastructure and personnel for the 
supervision of treatment and the time and costs 
involved in the requirement for the patient to travel to 
the health center every day or three times a week. 
Moreover, the DOT component can potentially 
intensify the stigma associated with TB and diminish a 
patient’s ability to maintain privacy about their health 
[14]. 
Although some TB treatment programs have 
health workers who conduct DOT in patients’ homes 
rather than health facilities, no official numbers exist 
on how many programs administer TB treatment 
through this method [15].  
Nonetheless, between 1995 and 2012, an 
estimated 56 million individuals were successfully 
treated for tuberculosis under the DOTS/Stop TB 
strategy in 184 countries [15]. Worldwide, 
approximately 86 % of TB patients complete 
treatment; however, treatment success and cure rates 
vary widely by geographic region and per capita 
income [16]. DOT is only one part of the 
comprehensive case management of each patient 
with TB. Rigorous monitoring of all patients who have 
started treatment and rapid response to ensure that 
patients who interrupt their treatment are returned to 
care are also essential components of effective case 
management and community-wide TB control. 
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On the basis of the results from our study we 
can conclude that DOT visits to TB patients are 
useful, contribute patients to complete therapeutic 
regime without interruption, take care for every 
individual patient effectively, and protect the rest of 
society by preventing the development and spread of 
TB, including drug-resistant strains. NTP in 
Macedonia and public health policy-makers should 
find the best way how to strengthen and continue with 
DOT in the future and assess which are the most 
important ingredients for success in our particular 
program. The prime responsibility of a TB control 
programme for patients and the community is to 
ensure cure while preventing drug resistance. DOT is 
the only current documented means to meet this 
commitment. 
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